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Abstract 
Background: Inflammatory mediators that weaken and cause membrane rupture are released during the course of 
genital infections among pregnant women. We set out to determine the association of common genital infections 
(Trichomonas vaginalis, syphilis, Neisseria gonorrhea, Chlamydia trachomatis, Group B Streptococcus, Bacterial vaginosis, 
Herpes Simplex Virus Type 2 and candidiasis) and premature rupture of membranes in Mulago hospital, Uganda.
Methods: We conducted an unmatched case–control study among women who were in the third trimester of 
pregnancy at New Mulago hospital, Uganda. The cases had PROM and the controls had intact membranes during 
latent phase of labour in the labour ward. We used interviewer-administered questionnaires to collect data on socio-
demographic characteristics, obstetric and medical history. Laboratory tests were conducted to identify T. vaginalis, 
syphilis, N. gonorrhea, C. trachomatis, Group B Streptococcus, Bacterial vaginosis, Herpes Simplex Virus Type 2 (HSV-2) 
and candidiasis. Logistic regression models were used to estimate the odds ratios (OR) and 95 % CI of the association 
between genital infections and PROM.
Results: There was an association between PROM and abnormal vaginal discharge (OR = 2.02, 95 % CI 1.10–3.70 
and AOR = 2.30, 95 % CI 1.18–4.47), presence of candidiasis (OR = 0.27, 95 % CI 0.14–0.52 and AOR = 0.22, 95 % CI 
0.10–0.46) and T. vaginalis (OR = 2.98, 95 % CI 1.18–7.56 and AOR = 4.22, 95 % CI 1.51–11.80). However, there was 
no association between PROM and presence of C. trachomatis (OR = 2.05, 95 % CI 0.37–11.49) and HSV-2 serostatus 
(OR = 1.15, 95 % CI 0.63–2.09). Few or no patients with Bacterial vaginosis, Neisseria gonorrhoea, Group B streptococ-
cus or syphilis were identified among the cases and controls. Co-infection of Trichomoniasis and candidiasis was not 
associated with PROM (AOR = 1.34, 95 % CI 0.16–11.10). Co infection with T. vaginalis and C. trachomatis was associ-
ated with PROM (OR = 3.09, 95 % CI 1.21–7.84 and AOR = 4.22, 95 % CI 1.51–11.83).
Conclusion: Trichomonas vaginalis alone, T. vaginalis with C. trachomatis co-infection and abnormal per vaginal 
discharge were found as risk factors for PROM. There was no association of HSV-2 serostatus, syphilis, N. gonorrhea, 
C. trachomatis, Group B Streptococcus and Bacterial vaginosis with PROM. Candidiasis seemed to have a protective 
effect on PROM.
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Background
Genital infections are implicated in significant morbidi-
ties among women of reproductive age group especially 
during the pregnancy period [1]. Inflammatory cells pro-
duced by genital infections are implicated in weakening 
of the fetal membranes among pregnant women thus 
causing premature rupture of membranes (PROM) [2]. 
PROM is defined as rupture of membranes before onset 
of labour [3, 4].
PROM may occur when the fetus is 37 weeks or more 
of gestation (term PROM) or before 37 weeks’ gestation 
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(pre-PROM) [5]. PROM predisposes pregnant women 
and their unborn children to adverse outcomes such as 
maternal infection, fetal infection, umbilical cord com-
pression and prolapse, fetal demise, low Apgar score, pul-
monary hypoplasia, preterm delivery, low birth weights 
and fetal deformation [5]. Worldwide the prevalence of 
PROM ranges between 2 and 10 % [6]. In Mulago Hos-
pital, 12  % of the admissions in the high risk labour 
ward have PROM as per the obstetrics and gynaecology 
departmental records of the year 2012.
The aetiology of PROM is diverse [7]. It includes poly-
hydramnios, cervical incompetence, uterine abnormality, 
trauma and previous cervical conization or cone biopsy 
[5, 7]. Other factors that have been implicated include 
past obstetric history of PROM, black race, smoking of 
cigarettes, poor nutrition and genital infections [5].
Genital infections [such as Chlamydia trachomatis 
(CT), Trichomonas vaginalis (TV), candidiasis, syphi-
lis, bacterial vaginosis, Neisseria gonorrhoea and Group 
B Streptococcus] have been found to be associated with 
PROM [8]. T. vaginalis was found to weaken membranes 
in  vitro studies and prospective studies have found an 
association between T. vaginalis and PROM [9, 10]. Stud-
ies by Chow and by Blas have demonstrated association 
of Chlamydial infections with occurrence of PROM [11, 
12].
Women with Bacterial vaginosis BV (a condition where 
the normal flora of the vagina is disrupted causing abnor-
mal vaginal discharge) compared with women without 
BV were more likely to develop PROM [8]. Maternal 
syphilis was also found associated with poor obstetric 
outcomes including prematurity; a common outcome of 
preterm PROM [13]. The association of candidiasis with 
PROM is still controversial but recent studies showed 
a positive association that is supported by the reduc-
tion in incidence of PROM through treatment of can-
didiasis [14]. Having Neisseria gonorrhoea (NG) during 
pregnancy conferred a 6 times higher risk of develop-
ing PROM compared to not having NG [15]. The evi-
dence that Group B streptococci (GBS) may be a cause 
of PROM was supported by the fact that GBS causes an 
inflammatory responses in fetal membranes in experi-
mental and epidemiological studies [3].
Genital HSV-2 is a frequent infection among women in 
child bearing age group globally [16]. There is experimen-
tal evidence that herpetic infection in the cervix causes 
release of cytokines and other inflammatory mediators 
[17]. These inflammatory mediators when released dur-
ing infections of the genital tract of pregnant women are 
known to weaken and cause membrane rupture [18].
Despite the plausible association between genital infec-
tions and PROM, the findings from many studies are still 
inconsistent and it is unclear whether the proportion of 
women with confirmed genital infections differs among 
women with PROM and those without PROM. The 
objective of this study was to determine the association 
between common genital infections (T. vaginalis, Syphi-
lis, N. gonorrhea, C. trachomatis, Group B Streptococcus, 
Bacterial vaginosis, candidiasis and HSV-2) and PROM 
among women attending delivering in the national refer-
ral hospital in Kampala, Uganda.
Methods
Study design and participants
An unmatched case–control study was conducted in the 
high risk labour ward in Mulago Hospital, Uganda between 
June and November 2013 to assess the association between 
PROM and genital infections. Mulago Hospital is one of the 
large hospitals in East Africa with 1500 bed capacity [19]. It 
serves as the national referral hospital for Uganda as well 
as the teaching hospital for Makerere University College 
of Health Sciences and functions as district Hospital for 
Kampala district. It is located approximately 3 km north of 
Kampala city center. The hospital has several departments 
including obstetrics and gynecology that offer specialized 
clinical care. The hospital has three labour wards namely; 
upper Mulago, lower Mulago (risk labour) and private 
(6D&E). The study was conducted at Mulago Hospital’s 
two general labour wards (upper and lower Mulago). The 
hospital has 23,000–30,000 deliveries a year and 12 percent 
of those had either term PROM or Pre-PROM. There are 
two antenatal clinics, one in Old Mulago and the other in 
New Mulago. The antenatal clinic in New Mulago Hospital 
is run 3 times a week and on average 150–200 patients are 
seen on each clinic day. All pregnant women in the ante-
natal clinic are offered HIV testing as part of prevention of 
mother and child transmission of HIV. The mothers have a 
code written on the file denoting whether positive or nega-
tive as per departmental records 2012.
For inclusion into the study, we selected participants 
presenting to the antenatal and labour wards at or above 
28 weeks of gestation, 18 years and above who consented 
to the study. We recruited cases and controls by consecu-
tive sampling procedure until the sample size was realized. 
Cases were women with confirmed premature rupture of 
membranes. The diagnosis of PROM was made from his-
tory of draining of clear fluid that wet the perineum and 
run along the thighs and legs plus sterile speculum exami-
nation. The diagnosis of PROM at speculum examination 
was made if there was observation of fluid pooling in pos-
terior vaginal fornix or free flow of fluid from the cervix. 
The controls were women without PROM in latent phase 
of labour who were identified from the antenatal ward or 
the admission room of labour and met the inclusion cri-
teria for controls. Women in latent phase of labour had 
uterine contractions, cervical effacement and dilatation 
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up to 3  cm. The women in latent phase of labour with 
unruptured membranes were thus appropriate controls. 
These women were obviously not cases and could not be 
mistaken for such. In addition, there was ample time for 
consent. Assuming seroprevalence of genital HSV-2 of 
49 % [20], 80 % study power, 95 % confidence interval and 
a minimum odds ratio of 2.4 of the association between 
PROM and genital infections, we estimated a minimum 
sample size of 87 cases and 87 controls (1:1) [21].
Data collection
Interviewer-administered questionnaires were used to 
collect socio-demographic characteristics such as age, 
education, religion, occupation, tribe, gravidity and mari-
tal status. Sexual history such as age at first sexual expe-
rience, number of sexual partners, circumcision status 
of the partner and partner with multiple sexual partners 
was also collected. In addition, we collected gynaecologi-
cal history [history of sexually transmitted infections in 
woman and partner(s), condom use in the woman and her 
partner(s) and history of operations on the cervix]. Other 
history sought included: obstetric history (past history 
of PROM and history of trauma to the cervix) and HIV 
status (from the antenatal and admission records. Other 
exposure variables were results from laboratory investi-
gations for the selected genital infections (cervical swabs 
for N. gonorrhea and C. trachomatis and vaginal swabs 
for T. vaginalis, Streptococcus agalactiae and candidiasis,) 
and HSV-2 serology. Patients diagnosed with PROM were 
given prophylactic antibiotics whilst those with genital 
infections were given the appropriate medication.
Assessment for genital infections
We drew two milliliters of blood from the vein in the 
cubital fossa using sterile technique and this was taken 
for HSV-2 and Syphilis serology. The blood samples were 
labelled and delivered to the Medical and molecular Lab-
oratory of the Makerere university College of health sci-
ences within 4 h. We performed a HerpeSelect 2 ELISA 
Ig G (to glycoprotein G) serology test (Focus Diagnos-
tics, CA, USA). This test uses purified recombinant 
type-specific gG-2 antigen immobilized on polystyrene 
microwells and the procedure done was as per the manu-
facturer instructions. The results are reported as positive 
or negative (where index values <0.9 are negative and 1.1 
and above are positive. Index values between 0.9 and 1.0 
(inclusive) were classified as equivocal and these were 
then repeated. We reclassified OD index values from 1.1 
to 3.4 as “low positive” and more than 3.4 as “high posi-
tive” [22].
We performed a RPR (Rapid Plasma Reagin) for syphi-
lis using some of the sera above where results read reac-
tive or non-reactive. Reactive test was demonstrated 
by agglomerates in the centre or the periphery of the 
test circle. A non-reactive test was indicated by an even 
appearance of the mixture. All reactive tests had a con-
firmatory ‘Treponema pallidum haemagglutination test 
(TPHA)’ performed [23].
We then removed five swabs (four vaginal and one 
cervical) for the other genital infections. Swab 1 was a 
cervical swab which was analysed by gram stain for N. 
gonorrhoea and by Chlamydia antigen test card for C. 
trachomatis [24].
Two high vaginal swabs were taken from the posterior 
vaginal fornix, one of them was taken for wet preparation 
and tested for candidiasis and T. vaginalis as described 
in Brown’s study [25]. The other high vaginal swab was 
taken for DNA PCR for T. vaginalis using the proce-
dure used in a previous study [26]. The other two vaginal 
swabs were taken from the lateral vaginal walls. A gram 
stain for Bacterial vaginosis as well as culture and sen-
sitivity for yeast cells were done from the vaginal swab 
three [27, 28]. Using vaginal swab 4, we performed cul-
ture and sensitivity tests for Group B Streptococcus [29].
Quality control
We had training for all research assistants on research 
procedures including the consent process and data col-
lection a week prior to the study and also had study 
meetings every week to review the challenges met and 
to resolve them. We also piloted the questionnaires. We 
used accredited laboratories that have buffer controls 
for all tests. The data was checked daily by the Princi-
pal Investigator for comprehensiveness prior to entry 
into the data base. Double data entry was done by two 
persons using the EPI-DATA programme and any miss-
ing data was checked against hospital records and other 
source documents.
Data analysis
Data was analysed in STATA version 12 (Stata Corp., 
College Station, TX, USA). Categorical data for cases 
and controls was summarized as counts and propor-
tions while continuous variables were summarized using 
means, and standard deviations. Some continuous vari-
ables like optical densities of HSV-2 were re-categorized 
into meaningful strata to be used for subsequent analy-
sis. We initially compared the baseline characteristics of 
the cases and controls for comparability. To assess risk 
factors for PROM, we compared the presence of genital 
infections among the cases and controls using odds ratios 
and 95 % CIs and their p values. P values less than 0.05 
were considered statistically significant. Multivariable 
analysis was done to determine the factors independently 
associated with PROM using logistic regression models. 
All variables with a p value of 0.05 or less and those with 
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sound biologic plausibility were included in the regres-
sion models and adjusted odds ratios (AOR) with their 
95  % Confidence intervals (CI) s were presented. The 
final regression model was evaluated using Hosmer–
Lemeshow goodness-of-fit test [30].
Ethical considerations
We obtained ethical approval from the Makerere Uni-
versity College of Health Sciences School of Medi-
cine Research and Ethics Committee, and the Uganda 
National Council of Science and Technology. We 
obtained informed consent from all the participants and 
confidentiality was observed for all the study documents.
Results
Distribution of age, gravidity, education level, marital sta-
tus, occupation, and religion were similar among cases 
and controls (Table 1).
There was an association between PROM and abnor-
mal vaginal discharge (OR  =  2.02, 95  % CI 1.10–3.70), 
presence of candidiasis (OR =  0.27, 95 % CI 0.14–0.52) 
and T. vaginalis (OR =  2.98, 95  % CI 1.18–7.56). There 
was an association between preterm gestation and 
PROM (OR = 4.27, 95 % CI 1.51–12.11). While there was 
an association between HSV-2 high positive optical den-
sities and PROM (OR = 2.08, 95 % CI 1.07–4.07), there 
was no association between HSV-2 serostatus and PROM 
(56 versus 53  %, OR =  1.15, 95  % CI 0.63–2.09). How-
ever, there was no association between HIV serostatus 
and having PROM (OR = 0.99, 95 % CI 0.42–2.34). Simi-
larly there was no association between presence of C. tra-
chomatis and PROM (OR =  2.05, 95  % CI 0.37–11.49). 
Few or no patients with Bacterial vaginosis, N. gonor-
rhoea, Group B Streptococcus or syphilis were identified 
among the cases and controls (Table 2).
The independent risk factors for PROM at multivariable 
analysis were abnormal vaginal discharge (AOR =  2.30, 
95 % CI 1.18–4.47) and T. vaginalis (AOR = 4.22, 95 % CI 
1.51–11.80) as shown in model 1 (Table  3). Candidiasis 
was found to be protective for PROM (AOR = 0.22, 95 % 
CI 0.10–0.46).
Co-infection of Trichomoniasis and candidiasis was 
associated with PROM (OR =  0.49, 95  % CI 0.27–0.90) 
at bivariate analysis but not at multivariable analysis 
(OR  =  1.34, 95  % CI 0.16–11.10) from model 2. From 
model 2, the only factor that had an independent asso-
ciation with PROM was abnormal per vaginal discharge 
(AOR = 2.30, 95 % CI 1.18–4.40) (Table 3).
Co infection with T. vaginalis and C. trachomatis was 
associated with PROM (OR  =  3.09, 95  % CI 1.21–7.84 
and AOR = 4.22, 95 % CI 1.51–11.84) as shown in model 
3 (Table 3).
Discussion
This study determined the association of selected geni-
tal infections (T. vaginalis, Syphilis, N. gonorrhea, C. 
trachomatis, group B Streptococcus, Bacterial vagino-
sis, candidiasis and HSV-2) and PROM in Mulago hos-
pital, Uganda. We found out that the odds of association 
between PROM with abnormal vaginal discharge and 
T. vaginalis was twice and thrice that without PROM 
respectively. There was no association between HSV-2 
serostatus, being HIV seropositivity or with presence of 
C. trachomatis with PROM. The association of HSV-2 
and PROM is not explored in this paper. Our study found 
few or no patients with bacterial vaginosis, N. gonor-
rhoea, Group B streptococcus or syphilis were identified 
among the cases and controls. Candidiasis was found to 
be protective for PROM; patients with PROM were 73 % 
less likely to have candidiasis compared with those with-
out PROM in this study.
Table 1 Baseline characteristics of  cases (PROM) & con-
trols (NO PROM) in Mulago Hospital, Uganda
The table shows that the distribution of age, gravidity, education level, marital 
status, occupation and religion of 87 cases and 87 controls was similar







 Catholic 30 (36.0) 32 (37.0) 0.071
 Muslim 27 (32.0) 20 (23.0)
 Protestant 24 (29.0) 12 (12.0)
 Born again 3 (4.0) 23 (26.0)
Marital status
 Single 9 (10.0) 7 (8.0) 0.680
 Married/cohabiting 76 (87.0) 66 (75.0)
 Divorce/separated 2 (3.0) 14 (17.0)
Age
 <19.99 10 (11.4) 9 (10.3) 0.290
 20–34.99 73 (84.0) 69 (79.4)
 ≥35 4 (4.6) 9 (10.3)
Gravidity
 Primegravida 31 (35.6) 31 (35.6) 1.000
 Gravida 2–4 47 (54.1) 48 (55.2)
 Gravida 5 & above 9 (10.3) 8 (9.2)
Education
 Primary and below 27 (31.0) 30 (34.0) 0.680
 Secondary and 
tertiary
60 (69.0) 57 (66.0)
Occupation
 House wife 31 (35.6) 33 (38.0) 0.200
 Employed/business 
woman
34 (39.1) 33 (37.0)
 Othersa 22 (25.3) 21 (25.0)
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The mechanisms of how infections increase the risk of 
PROM are through release of inflammatory cytokines and 
proteases [2]. There is epidemiological evidence by May-
mon et al. [18] that inflammatory cytokines were increased 
in patients with PROM. Indeed, genital infection have been 
found as a risk of poor pregnancy outcomes PROM [31, 32]. 
Furthermore, women with herpetic infections had increased 
cytokines in the cervical cells [17]. In having some genital 
infections may impair antimicrobial role of the pregnant 
cervix making it more susceptible to other microbes [17].
The strong association between having Trichomonas 
vaginalis (TV) infection and PROM found in our study 
is supported by in vitro studies that demonstrated 80 % 
reduction in term fetal membranes tension leading to 
membrane rupture when incubated with fresh T. vagi-
nalis isolates [9]. There is experimental evidence that 
inflammatory proteases are involved in the T. vaginalis 
induced membrane rupture [9]. Our results are also simi-
lar to results from a prospective study in Kashan (Iran) 
among 450 pregnant women where TV was associated 
Table 2 Bivariate analysis for genital symptoms and infections among cases (had PROM) and controls (without PROM)
We assessed the association between PROM and: abnormal vaginal discharge, history of painful genital ulcer, candidiasis, Trichomonas vaginalis, preterm labour, HSV-2 
serostatus, HSV-2 titres, HIV, bacterial vaginosis, Neisseria gonorrhoea, Group B streptococcus and with syphilis. The italicized odds ratios had a significant association 
with PROM (abnormal vaginal discharge, candidiasis, Trichomonas vaginalis, and preterm labour and HSV-2 titres)





P value OR (95 % CI)
Abnormal vaginal discharge
 Yes 47 (54.0) 32 (36.8) 0.023 2.02 (1.10–3.70)
 No 40 (46.0) 55 (63.2)
Painful genital ulcer history
 Yes 9 (10.3) 3 (3.4) 0.087 3.23 (0.84–12.37)
 No 78 (89.7) 84 (56.6)
HSV-2 serology
 Positive 49 (56.0) 46 (53.0) 0.648 1.15 (0.63–2.09)
 Negative 38 (44.0) 41 (56.6)
HSV-2 ELISA optical densities
 >3.4 (high positives) 32 (37.0) 19 (22.0) 0.032 2.08 (1.07–4.07)
 ≤3.4 (negative or low positive) 55 (63.0) 68 (78.0)
HIV status
 Positive 12 (13.8) 12 (13.8) 0.098 0.99 (0.42–2.34)
 Negative 75 (86.2) 75 (86.2)
Candida
 Positive 18 (20.7) 43 (49.4) <0.001 0.27 (0.14–0.52)
 Negative 69 (79.3) 44 (50.6)
Trichomonas vaginalis
 Positive 18 (20.7) 7 (8.0) 0.02 2.98 (1.18–7.56)
 Negative 69 (79.3) 80 (92.0)
Bacterial vaginosis
 Positive 0 (0.0) 2 (2.3) a
 Negative 87 (100.0) 85 (97.7)
Neisseria gonococcus
 Positive 0 (0.0) 1 (1.1) a
 Negative 87 (100.0) 86 (98.9)
Chlamydia trachomatis
 Positive 4 (4.6) 2 (2.3) 0.415 2.05 (0.37–11.49)
 Negative 83 (95.4) 85 (97.7)
Syphilis
 Positive 0 (0.0) 0 (0.0) a
 Negative 100 (100.0) 100 (100.0)
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with poor pregnancy outcomes such as preterm labour 
and PROM [33]. Similarly, epidemiological evidence from 
the USA showed TV was also associated with PROM 
[10]. In the US population overall TV prevalence was 
12 % among blacks which is slightly lower though com-
parable to the proportion in our study which was 14  % 
overall and 20.7 % among the women with PROM. Con-
trary to our findings, an analysis of secondary data for 
428 women in South Africa concluded that treatment of 
T. vaginalis in pregnant women did not reduce incidence 
of PROM. However, this was a smaller study compared to 
the previous large US studies and more prospective inter-
ventional studies towards T. vaginalis are still needed in 
low resource settings [34]. T. vaginalis is thus a risk factor 
for PROM.
The positive association between having an abnormal 
vaginal during pregnancy and PROM is also supported 
by studies done by Kaye et al. [35] in Uganda and Karat 
et al. [36] in India. The association between PROM and 
abnormal discharge, a common symptom of genital 
infections is most likely via inflammatory mediators [3]. 
One study that found no association between abnormal 
vaginal discharge and PROM was done in two centers in 
Brazil where women with genital infections had had full 
treatment courses, a factor that was not assessed in our 
study [37]. It was however not possible, from our findings 
to match each specific vaginal discharge to the confirmed 
genital infections as this was not differentiated from our 
study.
The association between candidiasis and rupture of 
membranes is still unclear. There is evidence of release 
of inflammatory cytokines during candida infestation 
[38]. We had postulated that these cytokines would 
cause membrane rupture. However our study and in a 
case–control study in India, patients with PROM were 
less likely to have candidiasis compared to those without 
PROM [36]. There is a possibility that the liquor amnii 
in patients with PROM washed out the yeast cells lead-
ing to non-detection but this is not proven. In contrast, a 
study by Rasti et al. [33] did not find candida as a risk fac-
tor for PROM. Furthermore, there was indirect evidence 
that candidiasis increased risk of membrane rupture in a 
Table 3 Genital infections and risk for PROM in Mulago Hospital
In this table we have three models after multivariable analysis. Model 1 included abnormal vaginal discharge, HIV status Trichomonas vaginalis, Chlamydia trachomatis, 
candidiasis and HSV-2 serostatus. The italicized odds ratios were either independent risk factors for PROM (abnormal vaginal discharge and Trichomonas) or protective 
factors (candidiasis). Model 2 is included to assess whether co-infection with Trichomoniasis and candidiasis was a risk factor for premature rupture of membranes and 
found that this interaction was not a risk factor for PROM at multivariable analysis. Model 3 is included to assess whether co-infection with Trichomonas vaginalis and 
Chlamydia trachomatis was associated with PROM and it is shown that this interaction is a risk factor for PROM
a The model 2 assesses interactions between Trichomonas vaginalis and candidiasis
b The model 3 assesses interaction between Trichomonas vaginalis and Chlamydia trachomatis
Variable Unadjusted odds ratio 
(95 % CI)
Adjusted odds ratio (95 %) 
in model 1
Adjusted odds ratio (95 %) 
in model 2a
Adjusted odds ratio (95 %) 
in model 3b
Abnormal vaginal discharge
 Yes 2.02 (1.10–3.70) 2.30 (1.18–4.47) 2.30 (1.18–4.40) 2.30 (1.18–4.46)
 No
HIV status
 Positive 0.99 (0.42–2.34) 1.38 (0.51–3.75) 1.30 (0.51–3.72) 1.38 (0.51–3.75)
 Negative
Trichomonas vaginalis
 Positive 2.98 (1.18–7.56) 4.22 (1.51–11.80) 3.70 (0.92–14.90)
 Negative
Chlamydia trachomatis
 Positive 2.05 (0.37–11.49) 1.91 (0.30–12.22) 1.92 (0.30–12.20)
 Negative
Candida
 Positive 0.27 (0.14–0.52) 0.22 (0.10–0.46) 0.16 (0.02–1.22) 0.22 (1.51–11.83)
 Negative
HSV-2
 Positive 1.15 (0.63–2.09) 0.95 (0.48–1.88) 0.94 (0.48–1.87) 0.95 (0.48–1.88)
 Negative
 Trichomonas and candida 0.49 (0.27–0.90) 1.34 (0.16–11.10) 1.34 (0.16–11.10)
 Trichomonas and  
Chlamydia
3.09 (1.21–7.84) 4.22 (1.51–11.83)
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study where use of antifungal medication reduced pre-
term labour and PROM [14]. The association of candida 
with PROM is still currently non- conclusive and needs 
to be explored more.
Our study showed no significant association between 
PROM and Chlamydia trachomatis (CT) yet studies by 
Chow et al. [11] in California and Blas et al. [12] in Wash-
ington have demonstrated association between CT and 
PROM. C. trachomatis infection in pregnancy women is 
known to cause release of inflammatory mediators that 
are implicated in membrane rupture [4]. In our study 
population, this relationship between C. trachomatis and 
PROM may not have been demonstrated because only 
4.6 % (4/87) of the cases and 23 % (2/87) had with con-
firmed CT which was lower than the 13  % Chlamydial 
case reports in Chow’s study. The cohort by Blas was a 
large prospective study and was also able to demonstrate 
an association of C. trachomatis with PROM. In our 
study we were not able to demonstrate with evidence that 
C. trachomatis is a risk factor for PROM.
Our study showed no significant association between 
HIV sero- status and PROM. However in a prospec-
tive cohort of 68 women with advanced HIV and 68 
HIV negative women showed an association between 
HIV and PROM (31 and 9 % respectively, p < 0.001) by 
Musana et  al. [39]. The explanation of the relationship 
between HIV and PROM is via inflammatory poly mor-
phonuclear cells that have been shown to be increased 
among HIV positive women cervical fluid [40]. Our study 
did not demonstrate this because we did not stage the 
patients according to their WHO clinical staging of the 
HIV disease. Musana’s study enrolled patients who had 
their WHO clinical staging done and demonstrated that 
PROM was associated with advanced HIV/AIDS disease 
stage.
None of the patients with PROM and 2.3  % of those 
without PROM in our study had bacterial vaginosis. In 
one study where an association of Bacterial vaginosis was 
found with PROM 29 % of patients with PROM and 11 % 
of patients without PROM had Bacterial vaginosis [41]. 
None of the patients with PROM and 1.1 % of those with-
out PROM in our study had N. gonorrhoea. In the study 
by Donders,among pregnant women in south Africa, 
where an association was found between PROM and 
gonococcal infections, the prevalence of N. gonorrhoea 
was there was 4.5  % in the population studied (6 times 
more among patients with PROM compared to those 
without PROM) [15]. In our study we did not identify 
any patient with GBS. However, Kessous found an asso-
ciation of PROM with GBS, where the prevalence of GBS 
in the women with PROM was 10.7 % while that among 
those without PROM was 7.9  % [42]. There is evidence 
that Group B Streptococcus, N. gonorrhoea and bacterial 
vaginosis cause release of cytokines and other inflamma-
tory modulators that can cause membrane rupture [4].
We did not identify any patient with syphilis yet in the 
Tanzanian study where an association between PROM 
and syphilis was found, the prevalence of syphilis was 
8  % [13]. Treponema Pallidum, the bacteria responsible 
for syphilis is also known to cause release of cell lysing 
enzymes when it infects the genital mucosa [43]. How-
ever, our study population had very low prevalence of 
GBS, N. gonorrhoea, bacterial vaginosis and syphilis thus 
no inferences could be drawn. The definitive reasons for 
the low prevalence of some genital infections remain 
unclear but could be that the patients may have been 
on antibiotics such as erythromycin which is given to all 
women with PROM. N. gonorrhea, syphilis and GBS are 
susceptible to erythromycin. We thus do not have evi-
dence that Group B Streptococcus, N. gonorrhoea, Bacte-
rial vaginosis and syphilis are risk factors for PROM in 
our setting.
Co‑infections
Co-infection with T. vaginalis and C. trachomatis was a 
risk factor for premature rupture of membranes in our 
study. Experimental studies have indeed shown that 
infections among patients presenting with premature 
rupture of membranes are multi microbial [44]. French 
et  al. (2006) found that single infection such as T. vagi-
nalis or C. trachomatis and those with multiple infections 
including T. vaginalis –C. trachomatis co-infections were 
risk factors for PROM [45]. The possible explanation for 
increased risk of PROM in multiple infections may be 
due to additive inflammatory response as explained by a 
model involving mixed bacterial infections [44].
Limitations
We did not collect the data of history of drug use and 
type of drug used at onset of PROM. Due to the low 
prevalence of N. gonorrhoea, syphilis, Group B Strepto-
coccus, bacterial vaginosis and C. trachomatis, we need a 
larger study to assess these infections and risk of PROM.
Implications
We need implementation research to strengthen routine 
screening and management for T. vaginalis among preg-
nant women so as to assess the effect of the intervention 
on reduction of incidence of PROM. We propose to cli-
nicians and programme managers that they need to con-
duct further tests to look for other infections in patients 
with one infection, so as to optimize prevention and care 
in women with premature rupture of membranes. Fur-
ther research to assess the effect of candida colonization 
on occurrence of PROM is also imperative. A prospective 
study on the membranes and placentae in patients with 
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PROM found to have Trichomoniasis is needed to define 
the causative pathway further. We also need a larger 
study to assess C. trachomatis, N. gonorrhoea, GBS, syph-
ilis and Bacterial vaginosis for risk of PROM.
Conclusions
Trichomonas Vaginalis alone, T. vaginalis with C. tra-
chomatis co-infection and abnormal per vaginal dis-
charge were found as a risk factors for PROM in Mulago 
hospital, Uganda. There was no association of HSV-2 
serostatus, Syphilis, N. gonorrhea, C. trachomatis, Group 
B streptococcus and Bacterial vaginosis with PROM. 
Candidiasis seemed to have a protective effect on PROM.
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